메뉴 건너뛰기




Volumn 19, Issue 6, 2011, Pages 1017-1024

Therapeutic potential of intracerebroventricular replacement of modified human Β-hexosaminidase B for GM2 gangliosidosis

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE B; GANGLIOSIDE GM2; SOMATOMEDIN B RECEPTOR;

EID: 79957890647     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.27     Document Type: Article
Times cited : (56)

References (36)
  • 1
    • 0032850439 scopus 로고    scopus 로고
    • Biochemical consequences of mutations causing the GM2 gangliosidoses
    • DOI 10.1016/S0925-4439(99)00074-5, PII S0925443999000745
    • Mahuran, DJ (1999). Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim Biophys Acta 1455: 105-138. (Pubitemid 29435983)
    • (1999) Biochimica et Biophysica Acta - Molecular Basis of Disease , vol.1455 , Issue.2-3 , pp. 105-138
    • Mahuran, D.J.1
  • 3
    • 0035168688 scopus 로고    scopus 로고
    • Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation
    • DOI 10.1182/blood.V97.1.327
    • Jeyakumar, M, Norfus, F, Tifft, CJ, Cortina-Borja, M, Butters, TD, Proia, RL et al. (2001). Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood 97: 327-329. (Pubitemid 32061278)
    • (2001) Blood , vol.97 , Issue.1 , pp. 327-329
    • Jeyakumar, M.1    Norflus, F.2    Tiff, C.J.3    Cortina-Borja, M.4    Butters, T.D.5    Proia, R.L.6    Perry, V.H.7    Dwek, R.A.8    Platt, F.M.9
  • 4
    • 67651242502 scopus 로고    scopus 로고
    • Miglustat in late-onset Tay-Sachs disease: A 12-month, randomized, controlled clinical study with 24 months of extended treatment
    • Shapiro, BE, Pastores, GM, Gianutsos, J, Luzy, C and Kolodny, EH (2009). Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment. Genet Med 11: 425-433.
    • (2009) Genet Med , vol.11 , pp. 425-433
    • Shapiro, B.E.1    Pastores, G.M.2    Gianutsos, J.3    Luzy, C.4    Kolodny, E.H.5
  • 7
    • 0025869216 scopus 로고
    • Replacement therapy for inherited enzyme defciency-macrophage-targeted glucocerebrosidase for Gaucher's disease
    • Barton, NW, Brady, RO, Dambrosia, JM, Di Bisceglie, AM, Doppelt, SH, Hill, SC et al. (1991). Replacement therapy for inherited enzyme defciency-macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 324: 1464-1470.
    • (1991) N Engl J Med , vol.324 , pp. 1464-1470
    • Barton, N.W.1    Brady, R.O.2    Dambrosia, J.M.3    Di Bisceglie, A.M.4    Doppelt, S.H.5    Hill, S.C.6
  • 8
    • 62149099925 scopus 로고    scopus 로고
    • Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1
    • Grabowski, GA, Kacena, K, Cole, JA, Hollak, CE, Zhang, L, Yee, J et al. (2009). Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1. Genet Med 11: 92-100.
    • (2009) Genet Med , vol.11 , pp. 92-100
    • Grabowski, G.A.1    Kacena, K.2    Cole, J.A.3    Hollak, C.E.4    Zhang, L.5    Yee, J.6
  • 10
    • 0035746540 scopus 로고    scopus 로고
    • Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial
    • Amalftano, A, Bengur, AR, Morse, RP, Majure, JM, Case, LE, Veerling, DL et al. (2001). Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 3: 132-138.
    • (2001) Genet Med , vol.3 , pp. 132-138
    • Amalftano, A.1    Bengur, A.R.2    Morse, R.P.3    Majure, J.M.4    Case, L.E.5    Veerling, D.L.6
  • 12
    • 59449083175 scopus 로고    scopus 로고
    • Long-term effcacy and safety of laronidase in the treatment of mucopolysaccharidosis i
    • Clarke, LA, Wraith, JE, Beck, M, Kolodny, EH, Pastores, GM, Muenzer, J et al. (2009). Long-term effcacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 123: 229-240.
    • (2009) Pediatrics , vol.123 , pp. 229-240
    • Clarke, L.A.1    Wraith, J.E.2    Beck, M.3    Kolodny, E.H.4    Pastores, G.M.5    Muenzer, J.6
  • 13
    • 39149118050 scopus 로고    scopus 로고
    • Mucopolysaccharidosis type II (Hunter syndrome): A clinical review and recommendations for treatment in the era of enzyme replacement therapy
    • Wraith, JE, Scarpa, M, Beck, M, Bodamer, OA, De Meirleir, L, Guffon, N et al. (2008). Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 167: 267-277.
    • (2008) Eur J Pediatr , vol.167 , pp. 267-277
    • Wraith, J.E.1    Scarpa, M.2    Beck, M.3    Bodamer, O.A.4    De Meirleir, L.5    Guffon, N.6
  • 14
    • 41149092265 scopus 로고    scopus 로고
    • Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
    • DOI 10.1038/mt.2008.9, PII MT20089
    • Chang, M, Cooper, JD, Sleat, DE, Cheng, SH, Dodge, JC, Passini, MA et al. (2008). Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis. Mol Ther 16: 649-656. (Pubitemid 351426165)
    • (2008) Molecular Therapy , vol.16 , Issue.4 , pp. 649-656
    • Chang, M.1    Cooper, J.D.2    Sleat, D.E.3    Cheng, S.H.4    Dodge, J.C.5    Passini, M.A.6    Lobel, P.7    Davidson, B.L.8
  • 15
    • 58149500258 scopus 로고    scopus 로고
    • Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease
    • Dodge, JC, Clarke, J, Treleaven, CM, Taksir, TV, Griffths, DA, Yang, W et al. (2009). Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease. Exp Neurol 215: 349-357.
    • (2009) Exp Neurol , vol.215 , pp. 349-357
    • Dodge, J.C.1    Clarke, J.2    Treleaven, C.M.3    Taksir, T.V.4    Griffths, D.A.5    Yang, W.6
  • 17
    • 49449090469 scopus 로고    scopus 로고
    • Neutralizing antibodies to therapeutic enzymes: Considerations for testing, prevention and treatment
    • Wang, J, Lozier, J, Johnson, G, Kirshner, S, Verthelyi, D, Pariser, A et al. (2008). Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment. Nat Biotechnol 26: 901-908.
    • (2008) Nat Biotechnol , vol.26 , pp. 901-908
    • Wang, J.1    Lozier, J.2    Johnson, G.3    Kirshner, S.4    Verthelyi, D.5    Pariser, A.6
  • 18
    • 0035826632 scopus 로고    scopus 로고
    • Identification of the 6-sulfate binding site unique to α-subunit-containing isozymes of human β-hexosaminidase
    • DOI 10.1021/bi0029200
    • Sharma, R, Deng, H, Leung, A and Mahuran, D (2001). Identifcation of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase. Biochemistry 40: 5440-5446. (Pubitemid 32458245)
    • (2001) Biochemistry , vol.40 , Issue.18 , pp. 5440-5446
    • Sharma, R.1    Deng, H.2    Leung, A.3    Mahuran, D.4
  • 19
    • 0037454663 scopus 로고    scopus 로고
    • A single site in human β-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside
    • DOI 10.1016/S0925-4439(02)00221-1
    • Sharma, R, Bukovac, S, Callahan, J and Mahuran, D (2003). A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside. Biochim Biophys Acta 1637: 113-118. (Pubitemid 36071604)
    • (2003) Biochimica et Biophysica Acta - Molecular Basis of Disease , vol.1637 , Issue.1 , pp. 113-118
    • Sharma, R.1    Bukovac, S.2    Callahan, J.3    Mahuran, D.4
  • 20
    • 5444246274 scopus 로고    scopus 로고
    • An α-subunit loop structure is required for GM2 activator protein binding by β-hexosaminidase A
    • DOI 10.1016/j.bbrc.2004.09.159, PII S0006291X04022193
    • Zarghooni, M, Bukovac, S, Tropak, M, Callahan, J and Mahuran, D (2004). An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A. Biochem Biophys Res Commun 324: 1048-1052. (Pubitemid 39361614)
    • (2004) Biochemical and Biophysical Research Communications , vol.324 , Issue.3 , pp. 1048-1052
    • Zarghooni, M.1    Bukovac, S.2    Tropak, M.3    Callahan, J.4    Mahuran, D.5
  • 21
    • 0026767475 scopus 로고
    • Analysis of the glycosylation and phosphorylation of the alpha-subunit of the lysosomal enzyme, beta-hexosaminidase A, by site-directed mutagenesis
    • Weitz, G and Proia, RL (1992). Analysis of the glycosylation and phosphorylation of the alpha-subunit of the lysosomal enzyme, beta-hexosaminidase A, by site-directed mutagenesis. J Biol Chem 267: 10039-10044.
    • (1992) J Biol Chem , vol.267 , pp. 10039-10044
    • Weitz, G.1    Proia, R.L.2
  • 22
    • 68749097166 scopus 로고    scopus 로고
    • Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene
    • Akeboshi, H, Kasahara, Y, Tsuji, D, Itoh, K, Sakuraba, H, Chiba, Y et al. (2009). Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene. Glycobiology 19: 1002-1009.
    • (2009) Glycobiology , vol.19 , pp. 1002-1009
    • Akeboshi, H.1    Kasahara, Y.2    Tsuji, D.3    Itoh, K.4    Sakuraba, H.5    Chiba, Y.6
  • 23
    • 4644316602 scopus 로고    scopus 로고
    • Enzyme therapy for Fabry disease: Neutralizing antibodies toward agalsidase alpha and beta
    • DOI 10.1111/j.1523-1755.2004.00924.x
    • Linthorst, GE, Hollak, CE, Donker-Koopman, WE, Strijland, A and Aerts, JM (2004). Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta. Kidney Int 66: 1589-1595. (Pubitemid 39298394)
    • (2004) Kidney International , vol.66 , Issue.4 , pp. 1589-1595
    • Linthorst, G.E.1    Hollak, C.E.M.2    Donker-Koopman, W.E.3    Strijland, A.4    Aerts, J.M.F.G.5
  • 24
    • 48749103550 scopus 로고    scopus 로고
    • Immune tolerance improves the effcacy of enzyme replacement therapy in canine mucopolysaccharidosis i
    • Dickson, P, Peinovich, M, McEntee, M, Lester, T, Le, S, Krieger, A et al. (2008). Immune tolerance improves the effcacy of enzyme replacement therapy in canine mucopolysaccharidosis I. J Clin Invest 118: 2868-2876.
    • (2008) J Clin Invest , vol.118 , pp. 2868-2876
    • Dickson, P.1    Peinovich, M.2    McEntee, M.3    Lester, T.4    Le, S.5    Krieger, A.6
  • 25
    • 0028304962 scopus 로고
    • Satisfying hydrogen bonding potential in proteins
    • DOI 10.1006/jmbi.1994.1334
    • McDonald, IK and Thornton, JM (1994). Satisfying hydrogen bonding potential in proteins. J Mol Biol 238: 777-793. (Pubitemid 24168633)
    • (1994) Journal of Molecular Biology , vol.238 , Issue.5 , pp. 777-793
    • McDonald, I.K.1    Thornton, J.M.2
  • 26
    • 0015222647 scopus 로고
    • The interpretation of protein structures: Estimation of static accessibility
    • Lee, B and Richards, FM (1971). The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55: 379-400.
    • (1971) J Mol Biol , vol.55 , pp. 379-400
    • Lee, B.1    Richards, F.M.2
  • 27
    • 0344837327 scopus 로고    scopus 로고
    • Crystal Structure of Human β-Hexosaminidase B: Understanding the Molecular Basis of Sandhoff and Tay-Sachs Disease
    • DOI 10.1016/S0022-2836(03)00216-X
    • Mark, BL, Mahuran, DJ, Cherney, MM, Zhao, D, Knapp, S and James, MN (2003). Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease. J Mol Biol 327: 1093-1109. (Pubitemid 36363715)
    • (2003) Journal of Molecular Biology , vol.327 , Issue.5 , pp. 1093-1109
    • Mark, B.L.1    Mahuran, D.J.2    Cherney, M.M.3    Zhao, D.4    Knapp, S.5    James, M.N.G.6
  • 29
    • 84986432905 scopus 로고
    • Accurate modeling of the intramolecular electrostatic energy of proteins
    • Dudek, MJ and Ponder, JW (1995). Accurate modeling of the intramolecular electrostatic energy of proteins. J Comput Chem 16: 791-816.
    • (1995) J Comput Chem , vol.16 , pp. 791-816
    • Dudek, M.J.1    Ponder, J.W.2
  • 30
    • 84962376142 scopus 로고    scopus 로고
    • Calculation of the reaction field due to off-center point multipoles
    • Kong, MJ and Ponder, JW (1997). Reaction feld methods for off-center multipoles. J Chem Phys 107: 481-492. (Pubitemid 127564373)
    • (1997) Journal of Chemical Physics , vol.107 , Issue.2 , pp. 481-492
    • Kong, Y.1    Ponder, J.W.2
  • 31
    • 0038424321 scopus 로고    scopus 로고
    • Analysis and application of potential energy smoothing and search methods for global optimization
    • Pappu, RV, Hart, RK and Ponder, JW (1998). Analysis and application of potential energy smoothing and search methods for global optimization. J Phys Chem B102: 9725-9742. (Pubitemid 128591379)
    • (1998) Journal of Physical Chemistry B , vol.102 , Issue.48 , pp. 9725-9742
    • Pappu, R.V.1    Hart, R.K.2    Ponder, J.W.3
  • 32
    • 0037899660 scopus 로고    scopus 로고
    • Polarizable atomic multipole water model for molecular mechanics simulation
    • Ren, P and Ponder, JW (2003). Polarizable atomic multipole water model for molecular mechanics simulation. J Phys Chem B107: 5933-5947.
    • (2003) J Phys Chem B , vol.107 , pp. 5933-5947
    • Ren, P.1    Ponder, J.W.2
  • 33
    • 33746691326 scopus 로고    scopus 로고
    • Inefficiency in GM2 ganglioside elimination by human lysosomal β-hexosaminidase β-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice
    • DOI 10.1248/bpb.29.1564
    • Itakura, T, Kuroki, A, Ishibashi, Y, Tsuji, D, Kawashita, E, Higashine, Y et al. (2006). Ineffciency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fbroblastic cell line derived from Sandhoff disease model mice. Biol Pharm Bull 29: 1564-1569. (Pubitemid 44166352)
    • (2006) Biological and Pharmaceutical Bulletin , vol.29 , Issue.8 , pp. 1564-1569
    • Itakura, T.1    Kuroki, A.2    Ishibashi, Y.3    Tsuji, D.4    Kawashita, E.5    Higashine, Y.6    Sakuraba, H.7    Yamanaka, S.8    Itoh, K.9
  • 34
    • 33846937578 scopus 로고    scopus 로고
    • Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies
    • DOI 10.1016/j.cca.2006.10.010, PII S000989810600698X
    • Tsuji, D, Higashine, Y, Matsuoka, K, Sakuraba, H and Itoh, K (2007). Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies. Clin Chim Acta 378: 38-41. (Pubitemid 46241058)
    • (2007) Clinica Chimica Acta , vol.378 , Issue.1-2 , pp. 38-41
    • Tsuji, D.1    Higashine, Y.2    Matsuoka, K.3    Sakuraba, H.4    Itoh, K.5
  • 35
    • 0023161242 scopus 로고
    • Enzymatic diagnosis of sphingolipidosis
    • In: Ginsbury V (ed) Academic Press: New York.
    • Suzuki, K (1987). Enzymatic diagnosis of sphingolipidosis. In: Ginsbury V (ed). Methods in Enzymology, vol. 138. Academic Press: New York. pp. 727-763.
    • (1987) Methods in Enzymology , vol.138 , pp. 727-763
    • Suzuki, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.